MedCity News - Healthcare technology news, life science current …
WEBHealthcare technology news, life science current events. 4 Lessons We Learned From The Change Healthcare Cyberattack Healthcare industry leaders think there is much to learn …
MedCity News
Print media611 Broadway Ste 907D, New York, NY 10012
News Coverage - MedCity News
WEBAt HIMSS24, Heather O'Sullivan, Mass General Brigham's president of healthcare at home, said that the health system wants to move 10% of all its medical patients to the home. …
Top Story Coverage - MedCity News
WEBReport: MA Insurers Denied 3.4M Prior Authorization Requests in 2022. About 7.4% of prior authorization requests submitted to MA insurers were denied in 2022, according to a …
- Estimated Reading Time: 4 mins
MedCity Knowledge Hub - MedCity Knowledge Hub
WEBOur library of free downloadable content includes white papers, webinars, product guides, case studies, industry analysis and much more, provided by experts and vendors within …
About Us - MedCity News
WEBAbout Us. MedCity News is the leading online news source for the business of innovation in healthcare. We offer insight into what’s next and what matters with a mix of breaking …
MedCity Podcasts - MedCity News
WEBChange is the only constant. Once a month, MedCity News’ Editor-in-Chief, Arundhati Parmar, invites a guest whose vision is to help the industry pivot to become more patient …
Health Tech Coverage - MedCity News
WEBSounder Benefits Launches To Advance Employee Health Benefits. Sounder Benefits, which was built at Redesign Health, launched last week with $7.5 million in funding. The …
About MedCity News – Engage
WEBMedCityNews.com is a destination site focused on B2B healthcare innovation for decision makers in the healthcare industry. It offers insight and breaking news into what’s next …
Hospitals Coverage - MedCity News
WEBWhy More Than 30% of Rural Hospitals Are at Risk of Closure. More than 700 hospitals across the rural U.S. are at risk of closing due to their financial woes — and for more …
BioPharma Coverage - MedCity News
WEBIn a Phase 3 study, Eli Lilly’s tirzepatide led to a 94% reduction in the risk that obese or overweight prediabetes patients progress to type 2 diabetes. Lilly was already planning …